A twice-daily oral CBD/THC formulation rapidly and significantly reduces end-of-life agitation in hospice-eligible dementia patients, achieving sustained symptom relief through 12 weeks.
A twice-daily oral CBD/THC formulation rapidly and significantly reduces end-of-life agitation in hospice-eligible dementia patients, achieving sustained symptom relief through 12 weeks.
Share this Article
Recommended